00:55:34 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Prenumeration

Kalender

2025-02-14 Bokslutskommuniké 2024
2024-11-08 Kvartalsrapport 2024-Q3
2024-08-23 Kvartalsrapport 2024-Q2
2024-05-10 Ordinarie utdelning ORTI A 0.00 SEK
2024-05-10 Ordinarie utdelning ORTI B 0.00 SEK
2024-05-08 Kvartalsrapport 2024-Q1
2024-05-08 Årsstämma 2024
2024-02-16 Bokslutskommuniké 2023
2023-11-10 Kvartalsrapport 2023-Q3
2023-08-25 Kvartalsrapport 2023-Q2
2023-05-05 Ordinarie utdelning ORTI A 0.00 SEK
2023-05-05 Ordinarie utdelning ORTI B 0.00 SEK
2023-05-04 Kvartalsrapport 2023-Q1
2023-05-04 Årsstämma 2023
2023-02-17 Bokslutskommuniké 2022
2022-11-11 Kvartalsrapport 2022-Q3
2022-08-25 Kvartalsrapport 2022-Q2
2022-05-06 Ordinarie utdelning ORTI A 0.00 SEK
2022-05-06 Ordinarie utdelning ORTI B 0.00 SEK
2022-05-05 Årsstämma 2022
2022-04-27 Kvartalsrapport 2022-Q1
2022-02-16 Bokslutskommuniké 2021
2021-11-12 Kvartalsrapport 2021-Q3
2021-08-20 Kvartalsrapport 2021-Q2
2021-05-06 Ordinarie utdelning ORTI B 0.00 SEK
2021-05-06 Ordinarie utdelning ORTI A 0.00 SEK
2021-05-05 Årsstämma 2021
2021-04-27 Kvartalsrapport 2021-Q1
2021-02-16 Bokslutskommuniké 2020
2020-11-10 Kvartalsrapport 2020-Q3
2020-08-21 Kvartalsrapport 2020-Q2
2020-05-13 Ordinarie utdelning ORTI A 0.00 SEK
2020-05-13 Ordinarie utdelning ORTI B 0.00 SEK
2020-05-04 Årsstämma 2020
2020-04-23 Kvartalsrapport 2020-Q1
2020-02-18 Årsstämma 1
2020-02-13 Bokslutskommuniké 2019
2020-02-13 Årsstämma 1
2019-10-25 Årsstämma 1
2019-08-22 Kvartalsrapport 2019-Q2
2019-05-07 Ordinarie utdelning ORTI A 0.00 SEK
2019-05-07 Ordinarie utdelning ORTI B 0.00 SEK
2019-05-06 Årsstämma 2019
2019-05-03 Kvartalsrapport 2019-Q1
2019-02-18 Extra Bolagsstämma 2019
2019-02-13 Bokslutskommuniké 2018
2018-11-20 Kvartalsrapport 2018-Q3
2018-08-24 Kvartalsrapport 2018-Q2
2018-05-04 Ordinarie utdelning ORTI B 0.00 SEK
2018-05-04 Ordinarie utdelning ORTI A 0.00 SEK
2018-05-03 Årsstämma 2018
2018-04-30 Kvartalsrapport 2018-Q1
2018-02-08 Bokslutskommuniké 2017
2017-11-21 Kvartalsrapport 2017-Q3
2017-08-22 Kvartalsrapport 2017-Q2
2017-05-12 Extra Bolagsstämma 2017
2017-05-02 Ordinarie utdelning ORTI B 0.00 SEK
2017-05-02 Kvartalsrapport 2017-Q1
2017-05-02 Ordinarie utdelning ORTI A 0.00 SEK
2017-04-28 Årsstämma 2017
2017-02-10 Bokslutskommuniké 2016
2016-10-24 Kvartalsrapport 2016-Q3
2016-07-13 Kvartalsrapport 2016-Q2
2016-05-09 Årsstämma 2016
2016-05-02 Kvartalsrapport 2016-Q1
2016-04-30 Ordinarie utdelning ORTI B 0.00 SEK
2016-04-30 Ordinarie utdelning ORTI A 0.00 SEK
2016-02-10 Bokslutskommuniké 2015
2015-10-20 Kvartalsrapport 2015-Q3
2015-07-13 Kvartalsrapport 2015-Q2
2015-04-30 Ordinarie utdelning ORTI B 0.00 SEK
2015-04-30 Ordinarie utdelning ORTI A 0.00 SEK
2015-04-29 Årsstämma 2015
2015-04-29 Kvartalsrapport 2015-Q1
2015-02-17 Bokslutskommuniké 2014
2014-10-27 Kvartalsrapport 2014-Q3
2014-07-11 Kvartalsrapport 2014-Q2
2014-04-30 Ordinarie utdelning ORTI A 0.00 SEK
2014-04-30 Ordinarie utdelning ORTI B 0.00 SEK
2014-04-29 Årsstämma 2014
2014-04-29 Kvartalsrapport 2014-Q1
2014-02-07 Bokslutskommuniké 2013
2013-10-18 Kvartalsrapport 2013-Q3
2013-07-12 Kvartalsrapport 2013-Q2
2013-04-30 Kvartalsrapport 2013-Q1
2013-04-22 Ordinarie utdelning ORTI A 0.00 SEK
2013-04-22 Ordinarie utdelning ORTI B 0.00 SEK
2013-04-19 Årsstämma 2013
2013-02-08 Bokslutskommuniké 2012
2012-10-18 Kvartalsrapport 2012-Q3
2012-07-12 Kvartalsrapport 2012-Q2
2012-05-04 Ordinarie utdelning ORTI B 0.00 SEK
2012-05-04 Ordinarie utdelning ORTI A 0.00 SEK
2012-05-03 Årsstämma 2012
2012-04-20 Kvartalsrapport 2012-Q1
2012-02-22 Bokslutskommuniké 2011
2011-10-14 Kvartalsrapport 2011-Q3
2011-08-12 Kvartalsrapport 2011-Q2
2011-05-31 Extra Bolagsstämma 2010
2011-05-05 Ordinarie utdelning ORTI A 0.00 SEK
2011-05-05 Ordinarie utdelning ORTI B 0.00 SEK
2011-05-04 Årsstämma 2011
2011-04-15 Kvartalsrapport 2011-Q1
2011-02-18 Bokslutskommuniké 2010
2010-10-14 Kvartalsrapport 2010-Q3
2010-08-12 Kvartalsrapport 2010-Q2
2010-05-04 Ordinarie utdelning ORTI A 0.00 SEK
2010-05-04 Ordinarie utdelning ORTI B 0.00 SEK
2010-05-03 Årsstämma 2010
2010-04-22 Kvartalsrapport 2010-Q1
2010-02-19 Bokslutskommuniké 2009
2009-11-12 Kvartalsrapport 2009-Q3
2009-08-14 Kvartalsrapport 2009-Q2
2009-05-07 Ordinarie utdelning ORTI A 0.00 SEK
2009-05-07 Ordinarie utdelning ORTI B 0.00 SEK
2009-05-06 Kvartalsrapport 2009-Q1
2009-05-06 Årsstämma 1
1998-04-23 Split ORTI A 1:2

Beskrivning

LandSverige
ListaSmall Cap Stockholm
SektorHälsovård
IndustriMedicinteknik
Ortivus är verksamt inom hälsovårdssektorn. Bolaget är specialiserade inom utvecklingen av mobila lösningar för sjukvården. Tjänsterna innefattar exempelvis övervaknings- och kommunikationslösningar som vidare används inom beslut- och stödsystem. Idag vidaresäljs lösningarna under flertalet varumärken med vardera affärsinriktning. Störst verksamhet innehas inom Norden, samt Europa. Ortivus etablerades under 1985 och har sitt huvudkontor i Danderyd.
2022-04-21 08:30:00

Ortivus’ goal is to reach an organic growth of an average of 15% annually while maintaining profitability, to achieve at least 25 MSEK profit within 4 years. Ortivus aims to increase sales to existing customers, gain additional market shares and reach new geographical markets in the prehospital and primary care segment.

Ortivus has built a strong market position facilitating assessments, record keeping and data sharing in prehospital care. MobiMed is currently used by over 12,000 paramedics and in more than 2,700 emergency vehicles. MobiMed is today installed in 45% of Sweden's ambulances and in 25% of the ambulances in the UK. Ortivus also support Singapore's entire mobile emergency care, with approximately 1,300 MobiMed users. In primary care, that is a new segment for Ortivus, has a customised version of MobiMed been installed in several Swedish regions during 2021.
 
Ortivus has in-house sales and service organisations in the Nordics as well as in the UK. MobiMed are however, delivered to Italy and Singapore through our local partners. Ortivus has in the recent years developed a well-functioning strategic partnership model where the company, in collaboration with locally established partners, can access and grow into new geographical markets. Strategic partnerships have recently been established in Australia, New Zealand, and Eastern Europe. This strategy makes it possible to handle large customer installations remotely, enabling a cost-effective growth.
 
Ortivus’ offering consists of the MobiMed platform that can be divided into three different product groups:

  • MobiMed Monitor, that in real time measures, monitors and shares ECG and vital signs such as blood pressure and oxygenation,
  • MobiMed ePR, an electronic patient record for clinical documentation and advanced decision support, and
  • MobiMed Life, a portfolio of stand-alone defibrillators.

With a weight of only 3.5 kg, MobiMed is created for optimal ergonomics and a demanding work out in the field. Through two-way communication, it is possible to consult medical experts at a distance, while clinical documentation and patient data are seamlessly integrated into the hospital records. For three decades, Ortivus has supplied reliable equipment for prehospital and cardiac care. The company continues to develop innovative and user-friendly solutions in close collaboration with nurses and medical doctors.
 
Market Conditions
The fast development of communication technology and cloud-based services makes it possible for a secure and efficient management of digital patient data. The digitization of patient information, such as medical history, current medication, and allergies, is made possible through electronic record keeping. The transition from record keeping using paper and pen to electronic records with advanced decision support, facilitates assessments and improves treatment outcomes. The quality of care is thereby enhanced while the efficiency is increased as real time patient information can be shared between different connected systems. In parallel, new mobile medical technology solutions are being developed to be used remotely to facilitate a patient-centered care.
 
The care need increases at the same rate as the growing and aging population and there is a demand to move healthcare closer to the patient. This is made possible by rapid technological improvements. The European primary care market, including home care, is expected to grow by 8% annually over the next five years*. A lot of focus will be on developing remote care, for example through mobile care teams. The prehospital care will also have to focus more on out of hospital care and the European market for remote monitoring is expected to grow by 14% annually until 2027**. Public healthcare funds will be directed more towards a patient-centered care - supported by digital solutions.
 
*Source: https://www.grandviewresearch.com/industry-analysis/europe-home-care-market
** Source: https://www.marketdataforecast.com/market-reports/europe-remote-patient-monitoring-market